Newbury Pharmaceuticals AB

Research Newbury Pharmaceuticals AB (NEWBRY) on Bullrun: market cap SEK 57.91M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNEWBRY
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencySEK
• Market capSEK 57.91M
• Financial periodQ1 2026
• RevenueSEK 8.45M
• Net income-SEK 4.56M
• Free cash flowSEK 2.26M
• Gross margin33.5%

Valuation Snapshot

latest market cap is SEK 57.91M.

About Newbury Pharmaceuticals AB

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.

Frequently asked questions

What is Newbury Pharmaceuticals AB's market cap?

Newbury Pharmaceuticals AB's market capitalization is SEK 57.91M.

What does Newbury Pharmaceuticals AB do?

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.